Simultaneous Occurrence of Inflammatory Bowel Disease and Myelodysplastic Syndrome due to Chromosomal Abnormalities in Bone Marrow Cells

被引:9
作者
Nakamura, Fumiyasu
Watanabe, Tomohiro [1 ]
Hori, Kimiko
Ohara, Yoshiaki
Yamashita, Kouhei [2 ]
Tsuji, Yoshihisa
Ueda, Yoshihide
Mikami, Sakae
Nakase, Hiroshi
Chiba, Tsutomu
机构
[1] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Hematol, Kyoto 6068507, Japan
关键词
Inflammatory bowel diseases; Myelodysplastic syndrome; Bone marrow; Cytokine; Apoptosis; INTESTINAL ULCERS; BEHCETS-DISEASE; COLITIS; TRANSPLANTATION; TRISOMY-8; THERAPY; ANTIGEN;
D O I
10.1159/000213486
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Although chromosomal abnormalities in bone marrow (BM) cells, such as trisomy 8, are risk factors for the development of inflammatory bowel diseases (IBD) as well as myelodysplastic syndrome (MDS), the mechanisms of how these cytogenetic abnormalities cause intestinal inflammation are poorly understood. Methods and Results: A 55-year-old man with a 3-month history of watery diarrhea, fever and abdominal pain was admitted. Blood examinations revealed pancytopenia. Pathological analysis and endoscopic images of the entire colon led to the diagnosis of IBD of unclassified type. BM examination showed that the pancytopenia was due to MDS and that his BM cells had dual chromosomal abnormalities: 47, XY, +1, der(1;7)(q10;p10), +8. Immunological studies using peripheral blood monocytes from this patient revealed that the dual chromosomal abnormalities of BM cells led to the development of colitogenic monocytes producing a large amount of pro-inflammatory cytokines and showing resistance to apoptosis upon stimulation with microbial antigens. Conclusion: An abnormal karyotype of BM cells is not only responsible for the development of MDS, but also for IBD in this case. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:215 / 219
页数:5
相关论文
共 15 条
[1]   Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities [J].
Chen, GB ;
Zeng, WH ;
Miyazato, A ;
Billings, E ;
Maciejewski, JP ;
Kajigaya, S ;
Sloand, EM ;
Young, NS .
BLOOD, 2004, 104 (13) :4210-4218
[2]   Concurrent inflammatory bowel disease and myelodysplastic syndromes [J].
Harewood, GC ;
Loftus, EV ;
Tefferi, A ;
Tremaine, WJ ;
Sandborn, WJ .
INFLAMMATORY BOWEL DISEASES, 1999, 5 (02) :98-103
[3]   Allogeneic bone marrow transplantation in Crohn's disease [J].
James, SP .
GASTROENTEROLOGY, 1998, 114 (03) :596-598
[4]   Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: Significance of trisomy 8 [J].
Kawabata, Hiroshi ;
Sawaki, Toshioki ;
Kawanami, Takafumi ;
Shimoyama, Kumiko ;
Karasawa, Hiromi ;
Fukushima, Toshihiro ;
Masaki, Yasufumi ;
Ogawa, Noriyoshi ;
Hirose, Yuko ;
Ozaki, Kazuaki ;
Shimanaka, Koshi ;
Takase, Shujiro ;
Ueno, Hiroshi ;
Umehara, Hisanori .
INTERNAL MEDICINE, 2006, 45 (22) :1309-1314
[5]   Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis - Behcet's syndrome [J].
Kimura, S ;
Kuroda, J ;
Akaogi, T ;
Hayashi, H ;
Kobayashi, Y ;
Kondo, M .
LEUKEMIA & LYMPHOMA, 2001, 42 (1-2) :115-121
[6]   Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behcet's disease by up-front cord blood transplantation [J].
Nonami, Atsushi ;
Takenaka, Katsuto ;
Sumida, Chinatsu ;
Aizawa, Kumiko ;
Kamezaki, Kenjiro ;
Miyamoto, Toshihiro ;
Harada, Naoki ;
Nagafuji, Koji ;
Teshima, Takanori ;
Harada, Mine .
INTERNAL MEDICINE, 2007, 46 (20) :1753-1756
[7]   Current concepts - Behcet's disease [J].
Sakane, T ;
Takeno, M ;
Suzuki, N ;
Inaba, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1284-1291
[8]   Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy [J].
Sloand, Elaine M. ;
Wu, Colin O. ;
Greenberg, Peter ;
Young, Neal ;
Barrett, John .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2505-2511
[9]   The immunology of mucosal models of inflammation [J].
Strober, W ;
Fuss, IJ ;
Blumberg, RS .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :495-549
[10]   Signalling pathways and molecular interactions of NOD1 and NOD2 [J].
Strober, W ;
Murray, PJ ;
Kitani, A ;
Watanabe, T .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (01) :9-20